Epigallocatechin-3-gallate promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells via PTEN

  • Authors:
    • Shifei Yao
    • Liang Zhong
    • Min Chen
    • Yi Zhao
    • Lianwen Li
    • Lu Liu
    • Ting Xu
    • Chunlan Xiao
    • Liugen Gan
    • Zhiling Shan
    • Beizhong Liu
  • View Affiliations

  • Published online on: July 27, 2017     https://doi.org/10.3892/ijo.2017.4086
  • Pages: 899-906
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Acute promyelocytic leukemia (APL) is a distinctive subtype of acute myeloid leukemia (AML) in which the hybrid protein promyelocytic leukemia protein/retinoic acid receptor α (PML/RARα) acts as a transcriptional repressor impairing the expression of genes that are critical to myeloid cell mutation. We aimed at explaining the molecular mechanism of green tea polyphenol epigallocatechin-3-gallate (EGCG) enhancement of ATRA-induced APL cell line differentiation. Tumor suppressor phosphatase and tensin homolog (PTEN) was found downregulated in NB4 cells and rescued by proteases inhibitor MG132. A significant increase of PTEN levels was found in NB4, HL-60 and THP-1 cells upon ATRA combined with EGCG treatment, paralleled by increased myeloid differentiation marker CD11b. EGCG in synergy with ATRA promote degradation of PML/RARα and restores PML expression, and increase the level of nuclear PTEN. Pretreatment of PTEN inhibitor SF1670 enhances the PI3K signaling pathway and represses NB4 cell differentiation. Moreover, the induction of PTEN attenuated the Akt phosphorylation levels, pretreatment of PI3K inhibitor LY294002 in NB4 cells, significantly augmented the cell differentiation and increased the expression of PTEN. These results therefore indicate that EGCG targets PML/RARα oncoprotein for degradation and potentiates differentiation of promyelocytic leukemia cells in combination with ATRA via PTEN.

References

1 

Melnick A and Licht JD: Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood. 93:3167–3215. 1999.PubMed/NCBI

2 

Lafage-Pochitaloff M, Alcalay M, Brunel V, Longo L, Sainty D, Simonetti J, Birg F and Pelicci PG: Acute promyelocytic leukemia cases with nonreciprocal PML/RARα or RARα/PML fusion genes. Blood. 85:1169–1174. 1995.PubMed/NCBI

3 

Mozziconacci MJ, Liberatore C, Brunel V, Grignani F, Arnoulet C, Ferrucci PF, Fernandez F, Sainty D, Pelicci PG, Birg F, et al: In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes. Genes Chromosomes Cancer. 22:241–250. 1998. View Article : Google Scholar : PubMed/NCBI

4 

Gianni M, Fratelli M, Bolis M, Kurosaki M, Zanetti A, Paroni G, Rambaldi A, Borleri G, Rochette-Egly C, Terao M, et al: RARalpha2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells. Oncotarget. 8:37041–37060. 2016.

5 

Vitaliano-Prunier A, Halftermeyer J, Ablain J, de Reynies A, Peres L, Le Bras M, Metzger D and de Thé H: Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation. Blood. 124:3772–3780. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Marasca R, Zucchini P, Galimberti S, Leonardi G, Vaccari P, Donelli A, Luppi M, Petrini M and Torelli G: Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As2O3 sensitive relapsed acute promyelocytic leukemia. Haematologica. 84:963–968. 1999.PubMed/NCBI

7 

Fatemi A, Safa M and Kazemi A: MST-312 induces G2/M cell cycle arrest and apoptosis in APL cells through inhibition of telomerase activity and suppression of NF-kappaB pathway. Tumour Biol. 36:8425–8437. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Huang Y, Kumazoe M, Bae J, Yamada S, Takai M, Hidaka S, Yamashita S, Kim Y, Won Y, Murata M, et al: Green tea polyphenol epigallocatechin-O-gallate induces cell death by acid sphingomyelinase activation in chronic myeloid leukemia cells. Oncol Rep. 34:1162–1168. 2015.PubMed/NCBI

9 

Iwasaki R, Ito K, Ishida T, Hamanoue M, Adachi S, Watanabe T and Sato Y: Catechin, green tea component, causes caspase-independent necrosis-like cell death in chronic myelogenous leukemia. Cancer Sci. 100:349–356. 2009. View Article : Google Scholar : PubMed/NCBI

10 

Vezina A, Chokor R and Annabi B: EGCG targeting efficacy of NF-kappaB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells. Cancer Immunol Immunother. 61:2321–2331. 2012. View Article : Google Scholar

11 

Lee HS, Jun JH, Jung EH, Koo BA and Kim YS: Epigalloccatechin-3-gallate inhibits ocular neovascularization and vascular permeability in human retinal pigment epithelial and human retinal microvascular endothelial cells via suppression of MMP-9 and VEGF activation. Molecules. 19:12150–12172. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Liu L, Hou L, Gu S, Zuo X, Meng D, Luo M, Zhang X, Huang S and Zhao X: Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo. Oncol Rep. 33:297–303. 2015.

13 

Tsukamoto S, Kumazoe M, Huang Y, Lesnick C, Kay NE, Shanafelt TD and Tachibana H: SphK1 inhibitor potentiates the anti-cancer effect of EGCG on leukaemia cells. Br J Haematol. 178:155–158. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Amin AR, Karpowicz PA, Carey TE, Arbiser J, Nahta R, Chen ZG, Dong JT, Kucuk O, Khan GN, Huang GS, et al: Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. Semin Cancer Biol. 35(Suppl): S55–S77. 2015. View Article : Google Scholar : PubMed/NCBI

15 

Britschgi A, Simon HU, Tobler A, Fey MF and Tschan MP: Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2. Br J Haematol. 149:55–64. 2010. View Article : Google Scholar : PubMed/NCBI

16 

Zhang L, Chen QS, Xu PP, Qian Y, Wang AH, Xiao D, Zhao Y, Sheng Y, Wen XQ and Zhao WL: Catechins induced acute promyelocytic leukemia cell apoptosis and triggered PML-RARα oncoprotein degradation. J Hematol Oncol. 7:752014. View Article : Google Scholar

17 

Bermúdez Brito M, Goulielmaki E and Papakonstanti EA: Focus on PTEN regulation. Front Oncol. 5:1662015. View Article : Google Scholar : PubMed/NCBI

18 

Whiteman DC, Zhou XP, Cummings MC, Pavey S, Hayward NK and Eng C: Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma. Int J Cancer. 99:63–67. 2002. View Article : Google Scholar : PubMed/NCBI

19 

Yang J, Liu J, Zheng J, Du W, He Y, Liu W and Huang S: A reappraisal by quantitative flow cytometry analysis of PTEN expression in acute leukemia. Leukemia. 21:2072–2074. 2007. View Article : Google Scholar : PubMed/NCBI

20 

Choorapoikayil S, Kers R, Herbomel P, Kissa K and den Hertog J: Pivotal role of Pten in the balance between proliferation and differentiation of hematopoietic stem cells in zebrafish. Blood. 123:184–190. 2014. View Article : Google Scholar

21 

Dragojlovic-Munther M and Martinez-Agosto JA: Multifaceted roles of PTEN and TSC orchestrate growth and differentiation of Drosophila blood progenitors. Development. 139:3752–3763. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Lee JE, Lim MS, Park JH, Park CH and Koh HC: PTEN promotes dopaminergic neuronal differentiation through regulation of ERK-dependent inhibition of S6K signaling in human neural stem cells. Stem Cells Transl Med. 5:1319–1329. 2016. View Article : Google Scholar : PubMed/NCBI

23 

Neri LM, Borgatti P, Tazzari PL, Bortul R, Cappellini A, Tabellini G, Bellacosa A, Capitani S and Martelli AM: The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. Mol Cancer Res. 1:234–246. 2003.PubMed/NCBI

24 

Huang J, Yan J, Zhang J, Zhu S, Wang Y, Shi T, Zhu C, Chen C, Liu X, Cheng J, et al: SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane. Nat Commun. 3:9112012. View Article : Google Scholar : PubMed/NCBI

25 

Morotti A, Panuzzo C, Crivellaro S, Carrà G, Guerrasio A and Saglio G: HAUSP compartmentalization in chronic myeloid leukemia. Eur J Haematol. 94:318–321. 2015. View Article : Google Scholar

26 

Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J, Yang H, Pavletich NP, Carver BS, Cordon-Cardo C, Erdjument-Bromage H, et al: Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell. 128:141–156. 2007. View Article : Google Scholar : PubMed/NCBI

27 

Song MS, Salmena L, Carracedo A, Egia A, Lo-Coco F, Teruya-Feldstein J and Pandolfi PP: The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature. 455:813–817. 2008. View Article : Google Scholar : PubMed/NCBI

28 

Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C and Pandolfi PP: Identification of a tumour suppressor network opposing nuclear Akt function. Nature. 441:523–527. 2006. View Article : Google Scholar : PubMed/NCBI

29 

Ferruzzi L, Turrini E, Burattini S, Falcieri E, Poli F, Mandrone M, Sacchetti G, Tacchini M, Guerrini A, Gotti R, et al: Hemidesmus indicus induces apoptosis as well as differentiation in a human promyelocytic leukemic cell line. J Ethnopharmacol. 147:84–91. 2013. View Article : Google Scholar : PubMed/NCBI

30 

Kim SH, Danilenko M and Kim TS: Differential enhancement of leukaemia cell differentiation without elevation of intracellular calcium by plant-derived sesquiterpene lactone compounds. Br J Pharmacol. 155:814–825. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Misra S, Selvam AK, Wallenberg M, Ambati A, Matolcsy A, Magalhaes I, Lauter G and Björnstedt M: Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells. Oncotarget. 7:74686–74700. 2016.PubMed/NCBI

32 

Song H, Li L, Zhong L, Yang R, Jiang K, Yang X and Liu B: NLS-RARα modulates acute promyelocytic leukemia NB4 cell proliferation and differentiation via the PI3K/AKT pathway. Mol Med Rep. 14:5495–5500. 2016.PubMed/NCBI

33 

Goebbels S, Wieser GL, Pieper A, Spitzer S, Weege B, Yan K, Edgar JM, Yagensky O, Wichert SP, Agarwal A, et al: A neuronal PI(3,4,5)P3-dependent program of oligodendrocyte precursor recruitment and myelination. Nat Neurosci. 20:10–15. 2017. View Article : Google Scholar

34 

Li Y, Prasad A, Jia Y, Roy SG, Loison F, Mondal S, Kocjan P, Silberstein LE, Ding S and Luo HR: Pretreatment with phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibitor SF1670 augments the efficacy of granulocyte transfusion in a clinically relevant mouse model. Blood. 117:6702–6713. 2011. View Article : Google Scholar : PubMed/NCBI

35 

Van Aller GS, Carson JD, Tang W, Peng H, Zhao L, Copeland RA, Tummino PJ and Luo L: Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. Biochem Biophys Res Commun. 406:194–199. 2011. View Article : Google Scholar : PubMed/NCBI

36 

Liu S, Wang XJ, Liu Y and Cui YF: PI3K/AKT/mTOR signaling is involved in (−)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells. Am J Chin Med. 41:629–642. 2013. View Article : Google Scholar

37 

Li RA, Traver D, Matthes T and Bertrand JY: Ndrg1b and fam49ab modulate the PTEN pathway to control T-cell lymphopoiesis in the zebrafish. Blood. 128:3052–3060. 2016.PubMed/NCBI

38 

Yang JM, Schiapparelli P, Nguyen HN, Igarashi A, Zhang Q, Abbadi S, Amzel LM, Sesaki H, Quiñones-Hinojosa A and Iijima M: Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization. Oncogene. 36:3673–3685. 2017. View Article : Google Scholar : PubMed/NCBI

39 

Ciechanover A: Proteolysis: From the lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol. 6:79–87. 2005. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

September 2017
Volume 51 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Yao, S., Zhong, L., Chen, M., Zhao, Y., Li, L., Liu, L. ... Liu, B. (2017). Epigallocatechin-3-gallate promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells via PTEN. International Journal of Oncology, 51, 899-906. https://doi.org/10.3892/ijo.2017.4086
MLA
Yao, S., Zhong, L., Chen, M., Zhao, Y., Li, L., Liu, L., Xu, T., Xiao, C., Gan, L., Shan, Z., Liu, B."Epigallocatechin-3-gallate promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells via PTEN". International Journal of Oncology 51.3 (2017): 899-906.
Chicago
Yao, S., Zhong, L., Chen, M., Zhao, Y., Li, L., Liu, L., Xu, T., Xiao, C., Gan, L., Shan, Z., Liu, B."Epigallocatechin-3-gallate promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells via PTEN". International Journal of Oncology 51, no. 3 (2017): 899-906. https://doi.org/10.3892/ijo.2017.4086